Using AI to Screen for Eligibility for Clinical Trials

Roupen Odabashian shared on LinkedIn:

“Using AI to Screen for Eligibility for Clinical Trials

Manual chart review and patient recruitment for clinical trials are among the most time-consuming and slow processes in enrolling patients.

This study in the NEJM AI is particularly interesting because it utilized AI to screen for participants in clinical trials.

The cost of using AI for recruiting patients is just cents per patient! This is mind-blowing. If used in the right context, it can accelerate one of the most daunting challenges in evidence generation.”

Read further.
Source: Roupen Odabashian/LinkedIn

Dr. Roupen Odabashian is an Internal Medicine Physician and Hematology/Oncology Fellow at the Karmanos Cancer Institute and is actively involved in pioneering cancer treatments and conducting clinical research.

In addition, he hosts a podcast at OncoDaily, engaging with leading experts in oncology to share valuable insights with the medical community. Dr. Odabashian also contributes his expertise as an advisor at Spiraldot Health and Mesh AI.